These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 100059)

  • 1. [Clebopride, a new orthopramide with potent and selective central antidopaminergic properties].
    Roberts DJ; Salazar W; Beckett PR; Nahorski SR
    Arch Farmacol Toxicol; 1978 Apr; 4(1):102-4. PubMed ID: 100059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of antiapomorphinic activity of metoclopramide, sulpiride and clebopride in the rat and dog].
    Salazar W; Colombo M; Llupia J; Roberts DJ
    Arch Farmacol Toxicol; 1978 Apr; 4(1):60-3. PubMed ID: 697404
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antagonism of pre- and postsynaptic dopamine receptors by clebopride and related orthopramides].
    Berga P; Beckett PR; Roberts DJ
    Arch Farmacol Toxicol; 1979 Dec; 5(3):144-6. PubMed ID: 546329
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides.
    Kohli JD; Glock D; Goldberg LI
    Adv Biochem Psychopharmacol; 1982; 35():97-108. PubMed ID: 6756064
    [No Abstract]   [Full Text] [Related]  

  • 5. The substituted benzamides--a novel class of dopamine antagonists.
    Jenner P; Marsden CD
    Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and pharmacological properties of a series of antidopaminergic piperidyl benzamides.
    Prieto J; Moragues J; Spickett RG; Vega A; Colombo M; Salazar W; Roberts DJ
    J Pharm Pharmacol; 1977 Mar; 29(3):147-52. PubMed ID: 15078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility.
    Alphin RS; Proakis AG; Leonard CA; Smith WL; Dannenburg WN; Kinnier WJ; Johnson DN; Sancilio LF; Ward JW
    Dig Dis Sci; 1986 May; 31(5):524-9. PubMed ID: 3698769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
    Imazu Y; Kobayashi K; Shomori T
    Seishin Shinkeigaku Zasshi; 1988; 90(10):845-52. PubMed ID: 3251268
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.
    Hall H; Ogren SO; Florvall L
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):211-5. PubMed ID: 6542298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 12. The benzamides: evidence for action at dopamine receptors--shortcomings of current models.
    Wazer DE; Rotrosen J; Stanley M
    Adv Biochem Psychopharmacol; 1982; 35():83-95. PubMed ID: 6756063
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry and pharmacology of benzamides].
    Boyer P
    Sem Hop; 1983 Mar; 59(12):832-5. PubMed ID: 6306780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
    Linnik MD; Butler BT; Gaddis RR; Ahmed NK
    J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of substituted benzamides in biochemical models of dopamine receptors.
    Kebabian JW; Tsuruta K; Cote TE; Grewe CW
    Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
    [No Abstract]   [Full Text] [Related]  

  • 16. A central site of action for benzamide facilitation of gastric emptying.
    Costall B; Gunning SJ; Naylor RJ; Simpson KH
    Eur J Pharmacol; 1983 Jul; 91(2-3):197-205. PubMed ID: 6617741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clebopride enhances contractility of the guinea pig stomach by blocking peripheral D2 dopamine receptor and alpha-2 adrenoceptor.
    Takeda K; Taniyama K; Kuno T; Sano I; Ishikawa T; Ohmura I; Tanaka C
    J Pharmacol Exp Ther; 1991 May; 257(2):806-11. PubMed ID: 1851838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted benzamide drugs as selective neuroleptic agents.
    Jenner P; Marsden CD
    Neuropharmacology; 1981 Dec; 20(12B):1285-93. PubMed ID: 6119638
    [No Abstract]   [Full Text] [Related]  

  • 19. The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    Kilpatrick GJ; el Tayar N; Van de Waterbeemd H; Jenner P; Testa B; Marsden CD
    Mol Pharmacol; 1986 Sep; 30(3):226-34. PubMed ID: 2943980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the induction of gastric emptying by clebopride and other antidopaminergic drugs].
    Llupiá J; Roberts DJ
    Arch Farmacol Toxicol; 1979 Dec; 5(3):147-9. PubMed ID: 546330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.